Takara Bio
4974.T
Financials · Consolidated
| Fiscal year ended | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 | 2020-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥45.0bn | ¥43.5bn | ¥78.1bn | ¥67.7bn | ¥46.1bn | ¥34.6bn |
| Operating income | ¥2.3bn | ¥3.0bn | ¥20.5bn | ¥28.9bn | ¥14.0bn | ¥6.3bn |
| Ordinary income | ¥2.6bn | ¥3.4bn | ¥20.7bn | ¥28.5bn | ¥14.2bn | ¥6.3bn |
| Net income (owners) | ¥1.0bn | ¥1.5bn | ¥16.0bn | ¥19.8bn | ¥9.5bn | ¥3.8bn |
| Total assets | ¥125.3bn | ¥121.3bn | ¥129.2bn | ¥115.7bn | ¥89.8bn | ¥75.0bn |
| Net assets / equity | ¥115.8bn | ¥111.8bn | ¥112.5bn | ¥96.1bn | ¥74.3bn | ¥66.6bn |
| Operating cash flow | ¥5.8bn | ¥1.7bn | ¥36.9bn | ¥7.0bn | ¥13.9bn | ¥6.3bn |
| EPS (basic) | ¥8.65 | ¥12.3 | ¥132.97 | ¥164.84 | ¥79.29 | ¥31.72 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 15
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2025-09-30 | Half-year | 67 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 196 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 67 figures · EDINET |
| 2023-04-01 → 2024-03-31 | Annual | 196 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 69 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 69 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 67 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 196 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 69 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 69 figures · EDINET |
| 2021-04-01 → 2022-03-31 | AnnualAmended | 196 figures · EDINET |
| 2020-04-01 → 2021-03-31 | AnnualAmended | 196 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 67 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 196 figures · EDINET |
| 2020-04-01 → 2021-03-31 | AnnualAmended | 196 figures · EDINET |
22 more reports are still being processed.